Itga4 Antibody: Quality Solutions for Your Research Needs

Discover our latest product, the Itga4 Antibody, brought to you by Alpha Lifetech Incorporation. This highly specific and reliable antibody is designed for the detection and study of integrin alpha 4 (Itgain various research applications, The Itga4 Antibody is meticulously validated to ensure exceptional performance in immunohistochemistry, flow cytometry, western blotting, and other experimental techniques. It is a valuable tool for investigating the role of Itga4 in cell adhesion, migration, and signaling pathways, Our antibody offers high sensitivity and specificity, allowing for accurate and reproducible results in your research. It is produced under stringent quality control standards to guarantee consistency and reliability in every experiment, With the Itga4 Antibody from Alpha Lifetech Incorporation, researchers can advance their understanding of Itga4 function and its involvement in various physiological and pathological processes. Trust in our expertise and commitment to delivering innovative and high-quality reagents for your scientific endeavors

Hot Selling Product

ADT1009-Abrilumab Biosimilar-Research Biosimilar Antibody

ADT1694-Vedolizumab Biosimilar-Anti-ITGA4/ITGB7 mAb-Research Grade

ALP64550-Recombinant Human ILT3/CD85k/LILRB4 Protein, His Tag

ALP64538-Recombinant Human ANGPTL4/Angiopoietin-like protein 4 Protein, His Tag

ALP64521-Recombinant Human CD172a/SHPS-1/SIRPA Protein, His Tag, Avi Tag

ADT1110-Cabiralizumab Biosimilar: Anti-CSF1R mab- Research Grade

Best Way To Choose Itga4 Antibody Factory More Than a Supplier - A Partner

When selecting an antibody supplier for your research or production needs, it’s crucial to find a partner who can not only provide quality products but also support your long-term scientific goals. At Alpha Lifetech Inc., we understand that the relationship between a supplier and a researcher goes beyond mere transactions; it’s about collaboration and innovation. Founded by a team of experts in membrane Protein production and monoclonal development, we offer an extensive portfolio of nearly 10,000 high-quality reagents, including spot membrane proteins, cytokines, and drug target antibodies that cater to diverse research applications. Choosing Alpha Lifetech as your antibody partner means accessing not just our products but also our expertise. Our scientists are committed to helping you optimize your research processes, whether through customized solutions or technical support. By fostering a partnership, we aim to empower you to achieve remarkable breakthroughs. In an era where scientific progress depends on reliable and innovative reagents, aligning with a dedicated partner like Alpha Lifetech Inc. positions you to stay ahead in your field and meet your project milestones with confidence.

Best Way To Choose Itga4 Antibody Factory More Than a Supplier - A Partner

Criteria	Importance Level	Evaluation
Quality Assurance	High	ISO 9001 certified
Technical Support	Medium	24/7 Availability
Custom Solutions	High	Tailored antibody production
Pricing	Medium	Competitive offers
Delivery Time	High	Average 4-6 weeks
Reputation	High	Positive customer reviews

Related products

ADT1229-Etrolizumab Biosimilar-Anti-ITGA4_ITGB7 mAb-Research Grade

ADT1009-Abrilumab Biosimilar-Research Biosimilar Antibody

ADT1427-Natalizumab Biosimilar-Anti-ITGA4/CD49d mAb-Research Grade

ADT1694-Vedolizumab Biosimilar-Anti-ITGA4/ITGB7 mAb-Research Grade

ALP64550-Recombinant Human ILT3/CD85k/LILRB4 Protein, His Tag

ALP64569-Recombinant Mouse CD152/CTLA-4 Protein, His Tag

ALP64566-Recombinant Rat CD86/B7-2 Protein, His Tag

Trends in Antibody Production over the Months

Understanding the trends in antibody production is crucial when choosing a supplier that can also function as a reliable partner in research and development. The line graph above illustrates the monthly production output of antibodies over a span of seven months. Initially, the production starts modestly, with 30 units in January, reflecting the start-up phase where production processes and quality assessments are being established. As the months progress, there is a noticeable growth, peaking at 90 units in July. This upward trajectory signifies not only an increase in demand but also a supplier's capacity to scale up operations efficiently while maintaining quality. Such trends can indicate various factors such as enhancement in production protocols, investment in technology, and a robust supply chain. Data presented in this format allows potential partners to assess the supplier's capability to manage growth and deliver consistently, making it easier to choose the right antibody manufacturer that aligns with their research needs and expectations.